261G000315-EFMOROCTOCOG ALFA (various dosages)
About This Opportunity
TranslatedThis tender pertains to the procurement of EFMOROCTOCOG ALFA, a recombinant factor VIII product used in the treatment of hemophilia A. The tender specifies the requirement for various dosages of this medication, which is crucial for managing bleeding episodes in patients with this condition. The procurement is aimed at ensuring a consistent supply of this essential therapeutic agent to healthcare facilities. Interested suppliers must demonstrate compliance with regulatory standards and provide evidence of their capability to deliver the specified dosages in a timely manner. Additionally, bidders should be prepared to meet quality assurance requirements and provide documentation regarding the manufacturing processes. The location for the delivery of the product will be specified in the tender documents, and it is essential for bidders to consider logistics and distribution capabilities in their proposals. This tender is significant for the healthcare sector, particularly in improving patient outcomes for those affected by hemophilia A. Suppliers are encouraged to submit their bids in accordance with the guidelines provided in the tender documentation, ensuring that all necessary information is included to facilitate the evaluation process.
This is a supplies contract in the health and medical services, education and training and construction and civil works sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2.1 million.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "261G000315-EFMOROCTOCOG ALFA (varias dosagens)" has been issued in Portugal, reflecting the ongoing commitment of the Portuguese government to procure essential medical products.
This procurement specifically seeks EFMOROCTOCOG ALFA, a therapeutic agent used in the treatment of hemophilia A. The tender indicates a requirement for multiple dosages of this medication, accommodating the varied needs of patients based on their clinical conditions.
As part of the procurement process, interested suppliers must demonstrate compliance with stringent regulatory standards and provide evidence of their ability to deliver high-quality pharmaceutical products. Typical requirements for such tenders include detailed product specifications, adherence to Good Manufacturing Practices (GMP), and relevant certifications from health authorities. Suppliers may also be expected to present their logistics capabilities, ensuring timely delivery and maintenance of the drug's integrity during transportation.
The contract will be overseen by relevant health authorities in Portugal, ensuring that all procurement activities align with national healthcare objectives and standards. Potential bidders should be prepared to submit comprehensive proposals that outline their experience in pharmaceutical supply, pricing structures, and any additional support services they can offer, such as training for healthcare professionals on the usage of EFMOROCTOCOG ALFA.
This tender represents an important opportunity for pharmaceutical companies to engage with the public health sector in Portugal, contributing to the improved health outcomes for individuals living with hemophilia A.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 25, 2026. Last refreshed 3 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Santa Maria, E. P. E.
Unidade Local de Saúde de Santa Maria, E. P. E. has issued 1,315 procurement notices on BidsFactory, including 3 currently open and 1,293 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Is this tender still open?
No — the contract has already been awarded to PROFARIN - Distribuidora de Produtos Farmaceuticos, Lda. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Santa Maria, E. P. E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €2,107,116. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.